Ignite Creation Date:
2025-12-24 @ 3:24 PM
Ignite Modification Date:
2025-12-27 @ 12:46 PM
Study NCT ID:
NCT00391092
Status:
COMPLETED
Last Update Posted:
2015-08-28
First Post:
2006-10-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-09
Start Date Type:
None
Primary Completion Date:
2014-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-08
Completion Date Type:
ACTUAL
First Submit Date:
2006-10-20
First Submit QC Date:
None
Study First Post Date:
2006-10-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-07-21
Results First Submit QC Date:
None
Results First Post Date:
2015-08-14
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-08-21
Last Update Post Date:
2015-08-28
Last Update Post Date Type:
ESTIMATED